Literature DB >> 14570534

Contributions of disease severity and perceptions of primary and secondary control to the prediction of psychosocial adjustment to Parkinson's disease.

Anita D McQuillen1, Mark H Licht, Barbara G Licht.   

Abstract

Seventy-four people with Parkinson's disease (PD) completed questionnaires and were interviewed to determine the degree to which the severity of PD and perceptions of primary and secondary control over PD predicted psychosocial adjustment. Significant unique contributions to PD-related participation restrictions were made by disease severity (positive relationship) and perceived internal secondary control (negative relationship). Also, participation restrictions had a significant direct effect, and disease severity and perceived internal secondary control significant indirect effects, on both depressive symptomatology and life satisfaction. Results are consistent with theories that suggest the importance of enhancing internal secondary control processes in situations in which actual control over objective circumstances is limited, such as with chronic and progressive diseases like PD. 2003 APA, all rights reserved

Entities:  

Mesh:

Year:  2003        PMID: 14570534     DOI: 10.1037/0278-6133.22.5.504

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  9 in total

1.  A Novel Approach to Treating Anxiety and Enhancing Executive Skills in an Older Adult with Parkinson's Disease.

Authors:  Jan Mohlman; Dorian Hunter Reel; Daniel Chazin; Diana Ong; Bianca Georgescu; Jade Tiu; Roseanne D Dobkin
Journal:  Clin Case Stud       Date:  2010-02-01

2.  Self-management rehabilitation and health-related quality of life in Parkinson's disease: a randomized controlled trial.

Authors:  Linda Tickle-Degnen; Terry Ellis; Marie H Saint-Hilaire; Cathi A Thomas; Robert C Wagenaar
Journal:  Mov Disord       Date:  2010-01-30       Impact factor: 10.338

Review 3.  A motivational theory of life-span development.

Authors:  Jutta Heckhausen; Carsten Wrosch; Richard Schulz
Journal:  Psychol Rev       Date:  2010-01       Impact factor: 8.934

4.  Emotional benefits of mindfulness-based stress reduction in older adults: the moderating roles of age and depressive symptom severity.

Authors:  Autumn M Gallegos; Michael Hoerger; Nancy L Talbot; Jan A Moynihan; Paul R Duberstein
Journal:  Aging Ment Health       Date:  2013-05-22       Impact factor: 3.658

5.  Profile of social self-management practices in daily life with Parkinson's disease is associated with symptom severity and health quality of life.

Authors:  Linda Tickle-Degnen; Michael T Stevenson; Sarah D Gunnery; Marie Saint-Hilaire; Cathi A Thomas; Linda Sprague Martinez; Barbara Habermann; Elena N Naumova
Journal:  Disabil Rehabil       Date:  2020-04-01       Impact factor: 3.033

6.  Relationship of health locus of control with specific health behaviours and global health appraisal: a meta-analysis and effects of moderators.

Authors:  Cecilia Cheng; Mike W-L Cheung; Barbara C Y Lo
Journal:  Health Psychol Rev       Date:  2016-08-12

7.  Factors influencing psychosocial adjustment and quality of life in Parkinson patients and informal caregivers.

Authors:  María Victoria Navarta-Sánchez; Juana M Senosiain García; Mario Riverol; María Eugenia Ursúa Sesma; Sara Díaz de Cerio Ayesa; Sagrario Anaut Bravo; Neus Caparrós Civera; Mari Carmen Portillo
Journal:  Qual Life Res       Date:  2016-01-08       Impact factor: 4.147

8.  What is Functional Mobility Applied to Parkinson's Disease?

Authors:  Raquel Bouça-Machado; Walter Maetzler; Joaquim J Ferreira
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

9.  Patients and Health Professional's Perspective of Functional Mobility in Parkinson's Disease.

Authors:  Raquel Bouça-Machado; Nilza Gonçalves; Inês Lousada; Maria A Patriarca; Patrícia Costa; Raquel Nunes; Susana Dias; Ana Castro Caldas; Anabela Valadas; Patrícia Pita Lobo; Leonor Correia Guedes; Mário M Rosa; Miguel Coelho; Joaquim J Ferreira
Journal:  Front Neurol       Date:  2020-10-27       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.